MDR GEN POLIMORFIZMLARI - SARATON KASALLIGIDA KIMYOTERAPIYA CHIDAMLILIGI MARKERLARI

##article.authors##

  • KADIROVA Dilbar Abdullaevna
  • Alimxodjaev Lola Telmanovna
  • Ibrgimov Adil Ahmedovich

##article.subject##:

DNA, polimorfizm, MDR1, C3435T, SBS, NHL, Saraton

##article.abstract##

Maqsad: kimyoterapiya individual rejimini bashorat qilish polimorfik marker C3435T MDR1 gen tomonidan saraton bemorlarning shaxsiy genotip dori qarshilik aniqlash.

Material va Metodlar: tadqiqotlarni amalga oshirish paytida, Sut bezlari saratoni (SBS) (80 nafar bemor) va Nexodjkin  limfoma (NHL) (75 bemor) periferik qonli leykotsitlardan olingan DNK namunalari ishlatilgan.

Natijalar: MDR1 genining C3435T polimorf markeridagi bemorlarda genetik xususiyatlarni aniqlash farmakologik javobning xususiyatini taxmin qilish imkonini beradi, bu esa dori vositalarining samaradorligi va xavfsizligini oshirish imkonini beradi - doza, qo'llanilishning ko'pligi, administratsiya yo'li, dori vositalarini almashtirish va turli xil onkologik kasalliklar uchun farmakoterapiyani individuallashtirishning haqiqiy imkoniyati. Ko'krak bezi saratoni va Nexodjkin limfoma bilan kasallangan sog'lom donorlar va onkologik bemorlar orasida genotiplarning paydo bo'lish chastotasini aniqlash o'tkazildi

Xulosa: Ko'krak bezi saratoni va Hodgkin bo'lmagan limfoma uchun TT homozigot genotipining chastotasi CC va CT genotiplarining paydo bo'lishidan yuqori ekanligini ko'rsatadi.

Библиографические ссылки

Ambudkar S.V., Dey S., Hrycyna C.A. Biochemical, cellular, and pharmacological aspects of the multidrug transporter//Annu. Rev. Pharmacol. Toxicol.- 2011. - V. 39. - P. 361-398

Al-Mahayri Z.N.,Patrinos G.P. , Ali1 B.R. Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy. Front. Pharmacol., 2020. Vol. 11. P.1-16.

Rangel G. J., , Martínez M.O., Flores R.C, Saldana H.B. C3435T polymorphism in the MDR1 gene and breast cancer risk in northeastern Mexico. Int J Clin Exp Pathol. 2018. Vol. 11. N.2. P. 904-909.

Mekkey A. M., Abed A. S., Mohammed Z., Jawad N. N., Saad A. Molecular effect MDR1(C3435T) gene polymorphism on leukemia patients in Babylon province, Iraq. J. Annals of Tropical Medicine and Public Health 2020. Vol. 22. N.9. P.15-19.

Petryszyn P., Dudkowiak R., Gruca A., Tarnawska J.E., Cierniakowski P., C3435T Polymorphism of the ABCB1 Gene in Polish Patients with Inflammatory Bowel Disease: A Case–Control and Meta-Analysis Study. Genes 2021. N 12. P. 1-13

Lu S., Zhu X., Li W., Chen H., Zhou D. Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients. Front. Oncol. 2021. Vol. 11. P. 1-9.

Non-Hodgkin's Lymphoma Causes, Symptoms, and Treatment. Knott L., Willacy H. J.Oncologyyy. 2021. P. 1-12

Rangel G. J., , Martínez M.O., Flores R.C, Saldana H.B. C3435T polymorphism in the MDR1 gene and breast cancer risk in northeastern Mexico. Int J Clin Exp Pathol. 2018. Vol. 11. N.2. P. 904-909.

Загрузки

##submissions.published##

2022-05-31